Low but not undetectable early postoperative nadir serum cortisol predicts sustained remission in Cushing’s disease
Endocrine Oncology · 2022
DOI: 10.1530/eo-21-0026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Oncology, 2022. Verfasst von Anna Stroud und 7 weiteren Autor:innen. Beteiligte Einrichtung: Rhinology and Skull Base Research Group, St Vincent's Centre for Applied Medical Research, Sydney, Australia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Transsphenoidal surgery (TSS) is the first-line treatment for Cushing’s disease. The objectives of the study were to determine remission and recurrence rates after TSS for Cushing’s disease, identify factors that predict these outcomes, and define the threshold for postoperative morning serum cortisol (MSeC) that most accurately predicts sustained remission.
Methods
Records were retrospectively reviewed for consecutive adults undergoing TSS for Cushing’s disease at a tertiary centre (1990–2019). Remission was defined as MSeC
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rhinology and Skull Base Research Group, St Vincent's Centre for Applied Medical Research, Sydney, Australia.
- St Vincent's Hospital Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, Australia.
- Garvan Institute of Medical Research, Sydney, Australia.
- Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.
- Faculty of Medicine, Notre Dame University, Sydney, Australia.
- Institute of Academic Surgery, Royal Prince Alfred Hospital, Sydney, Australia.
ORCID-Profile: Anna Stroud, Ann McCormack
Zitieren
APA
Stroud, A., Dhaliwal, P., Harvey, R. J., Alvarado, R., Jonker, B. P., Winder, M. J., Grayson, J. W., & McCormack, A. (2022). Low but not undetectable early postoperative nadir serum cortisol predicts sustained remission in Cushing’s disease. Endocrine Oncology. https://doi.org/10.1530/eo-21-0026
Vancouver
Stroud A, Dhaliwal P, Harvey RJ, Alvarado R, Jonker BP, Winder MJ, et al. Low but not undetectable early postoperative nadir serum cortisol predicts sustained remission in Cushing’s disease. Endocrine Oncology. 2022. doi:10.1530/eo-21-0026
BibTeX
@article{Stroud2022,
author = {Stroud, Anna and Dhaliwal, Pearl and Harvey, Richard J and Alvarado, Raquel and Jonker, Benjamin P and Winder, Mark J and Grayson, Jessica W and McCormack, Ann},
title = {Low but not undetectable early postoperative nadir serum cortisol predicts sustained remission in Cushing’s disease},
journal = {Endocrine Oncology},
year = {2022},
doi = {10.1530/eo-21-0026}
}
EUVIMED